Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to implant FDA-approved novel defibrillation lead

prnewswire
02/02

The new technology is the world's smallest, catheter-delivered defibrillation lead

AUSTIN, Texas, Feb. 2, 2026 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to implant an FDA-approved novel defibrillation lead—a specialized, insulated wire that connects to an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT-Ds) device to the heart and corrects abnormal rhythm. The defibrillation lead is the world's smallest, catheter-delivered defibrillation lead, which allows for precise delivery and placement in the right ventricle.

The first procedure was performed by Robert Canby, M.D., and Amin Al-Ahmad, M.D., clinical cardiac electrophysiologists at TCAI, on Jan. 7. Dr. Canby also participated in the trial that led to FDA approval.

"When treating patients, safety and efficacy are paramount, and this novel technology allows us to achieve both with greater precision," said Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI. "This milestone is a testament to the Texas Cardiac Arrhythmia Institute's continued pursuit of innovation that will improve outcomes and access to life-saving care."

A lead senses the heartbeat and transmits signals to the implanted device, which then delivers therapy to correct or interrupt abnormally fast rhythms—called arrhythmias—that can result in sudden cardiac arrest. Existing defibrillation leads are larger in diameter, increasing the potential for future complications.

According to the Journal of the American Heart Association, an estimated 12.1 million people in the U.S. are expected to have atrial fibrillation—the most common arrhythmia—by 2030.

TCAI is a state-of-the-art Electrophysiology Center that includes six labs equipped with advanced technology where a group of esteemed cardiac electrophysiologists—led by Dr. Natale, a world-renowned expert in the field—perform a high volume of the most complex electrophysiology procedures.

SOURCE Texas Cardiac Arrhythmia Institute at St. David’s Medical Center

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10